Back to Search
Start Over
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- Source :
- Journal of the National Comprehensive Cancer Network. 20:1267-1275
- Publication Year :
- 2022
- Publisher :
- Harborside Press, LLC, 2022.
-
Abstract
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.
- Subjects :
- Adolescent
Oncology
Humans
Lymphoma, Large B-Cell, Diffuse
Child
Medical Oncology
Subjects
Details
- ISSN :
- 15401413 and 15401405
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Journal of the National Comprehensive Cancer Network
- Accession number :
- edsair.doi.dedup.....cbf67bc0a9329f1eb85467759ffae74d
- Full Text :
- https://doi.org/10.6004/jnccn.2022.0057